- Advertise
- About OncLive
- Editorial Board
- CureToday.com
- TargetedOnc.com
- CancerNetwork.com
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2021 MJH Life Sciences™ and OncLive. All rights reserved.
Latest Oncology News
Digital Health and Process Improvements Enhance Community-Based Patient Care
October 20th 2021
Lalan Wilfong, MD
A marked reduction in hospitalizations and emergency department visits are key metrics for value-based care programs. Quality improvement processes and electronic patient management systems may give practices a way to fully embrace these programs and remain mindful of cost while ensuring that patients receive high-quality care.
Novel Combination Immunotherapy Developed at Hollings Cancer Center to be Offered in Lung-MAP Trial
October 20th 2021
A bench-to-bedside-pioneered lung cancer immunotherapy developed at MUSC Hollings Cancer Center is to be included in one of the largest lung cancer clinical trials being offered by the National Cancer Institute.
Implementable Changes Could Improve QOL With Radiation-Related Mucositis in Head and Neck Cancer
October 20th 2021
Jessica Hergert
Anurag Singh, MD, discussed the potential advantage to treating patients with radiation therapy at specific times of day, how the utilization of prophylactic gabapentin has decreased the need for narcotics in managing oral mucositis in patients with head and neck cancer, and the potential use of single-fraction radiation therapy in oncology.
Study Highlights Racial, Ethnic Disparities in Post-Breast Cancer Surgery Emergency Department Visits
October 19th 2021
Courtney Marabella
Non-Hispanic Black women are approximately 40% more like to require a visit to the emergency department after breast cancer surgery, and Hispanic women are 11% more likely compared with non-Hispanic White women, according to results from a population-based study published in Breast Cancer Research and Treatment.
Avasopasem Misses the Mark for Radiotherapy-Induced Severe Oral Mucositis in Head and Neck Cancer
October 19th 2021
Kristi Rosa
The dismutase mimetic avasopasem manganese was not found to significantly reduce the incidence of severe oral mucositis in patients with locally advanced head and neck cancer who were receiving standard-of-care radiotherapy, missing the primary end point of the phase 3 ROMAN trial.
